Previous work by us has shown that a dual PI3Kɑ and PI3Kδ inhibitor, namely CNIO-PI3Ki, reduces obesity and elevates energy expenditure in mice. Here, PIK3CA is linked to obesity due to melanocortin 4 receptor deficiency.